| 21/03/25 | 07:00:10 | 21 Mar 2025 | | Issue of LTIP Options and Share Options | RNS |
| 21/03/25 | 07:00:08 | 21 Mar 2025 | | Results of Eisai Phase 2 pilot study | RNS |
| 06/02/25 | 07:00:07 | 6 Feb 2025 | | Novel findings using Parsortix | RNS |
| 29/01/25 | 07:00:04 | 29 Jan 2025 | | Analysis of CTC-DNA and ctDNA using Illumina assay | RNS |
| 24/01/25 | 10:05:00 | 24 Jan 2025 | | Parsortix used in research paper from ETH Zurich | RNS |
| 23/01/25 | 07:00:06 | 23 Jan 2025 | | Trading Update | RNS |
| 13/12/24 | 08:43:54 | 13 Dec 2024 | | HER2 presentation at SABCS | RNS |
| 15/11/24 | 07:00:06 | 15 Nov 2024 | | Research on HER2 assay kit showcased at AACR | RNS |
| 15/11/24 | 07:00:06 | 15 Nov 2024 | | Parsortix based PD-L1 assay showcased at AACR | RNS |
| 13/11/24 | 07:00:10 | 13 Nov 2024 | | ANGLE presents two posters at EACR | RNS |
| 11/11/24 | 07:00:10 | 11 Nov 2024 | | Parsortix enriched CTC & ctDNA in NSCLC patients | RNS |
| 17/10/24 | 07:00:09 | 17 Oct 2024 | | Publication demonstrates CTC profiling potential | RNS |
| 26/09/24 | 07:01:01 | 26 Sept 2024 | | 100th publication supporting Parsortix system use | RNS |
| 26/09/24 | 07:00:13 | 26 Sept 2024 | | Half-year Report | RNS |
| 23/09/24 | 07:00:07 | 23 Sept 2024 | | Exclusive agreement for DNA NGS panel | RNS |
| 19/09/24 | 07:00:11 | 19 Sept 2024 | | Agreement with Recursion Pharmaceuticals | RNS |
| 17/09/24 | 07:00:11 | 17 Sept 2024 | | Notice of Interim Results and Webcast | RNS |
| 22/08/24 | 07:00:15 | 22 Aug 2024 | | Data supporting FDA approval published in Journal | RNS |
| 01/08/24 | 07:00:20 | 1 Aug 2024 | | Independent Parsortix study | RNS |
| 18/07/24 | 10:08:22 | 18 Jul 2024 | | Standard form for notification of major holdings | RNS |
| 12/07/24 | 15:38:33 | 12 Jul 2024 | | Standard form for notification of major holdings | RNS |
| 11/07/24 | 15:07:44 | 11 Jul 2024 | | Result of 2024 Annual General Meeting | RNS |
| 21/06/24 | 07:00:12 | 21 Jun 2024 | | Result of open offer | RNS |
| 18/06/24 | 14:41:25 | 18 Jun 2024 | | Posting of 2023 Annual Report & Notice of the AGM | RNS |
| 11/06/24 | 07:00:10 | 11 Jun 2024 | | Parsortix and assays being showcased at EACR 2024 | RNS |
| 06/06/24 | 16:37:51 | 6 Jun 2024 | | Publication of Circular | RNS |
| 05/06/24 | 16:04:55 | 5 Jun 2024 | | Results of placing and subscription | RNS |
| 05/06/24 | 07:00:11 | 5 Jun 2024 | | Proposed Placing, Subscription and Open Offer | RNS |
| 05/06/24 | 07:00:10 | 5 Jun 2024 | | Preliminary Results | RNS |
| 16/05/24 | 07:00:13 | 16 May 2024 | | Study of ovarian cancer CTCs using Parsortix | RNS |
| 03/05/24 | 07:00:09 | 3 May 2024 | | New commercial agreement with large pharma | RNS |
| 24/04/24 | 07:00:10 | 24 Apr 2024 | | New commercial agreement with AstraZeneca | RNS |
| 22/04/24 | 07:00:10 | 22 Apr 2024 | | US and EU patents for innovative CellKeep™ slide | RNS |
| 08/04/24 | 07:00:09 | 8 Apr 2024 | | Parsortix HER2 assay showcased at AACR 2024 | RNS |
| 22/03/24 | 07:00:11 | 22 Mar 2024 | | Parsortix at European breast cancer conference | RNS |
| 22/01/24 | 07:00:11 | 22 Jan 2024 | | Potential utility in precision oncology | RNS |
| 10/01/24 | 12:57:47 | 10 Jan 2024 | | Standard form for notification of major holdings | RNS |
| 04/01/24 | 07:00:03 | 4 Jan 2024 | | Breakthrough clinical results | RNS |
| 02/01/24 | 07:00:05 | 2 Jan 2024 | | Contract announcement with Eisai Inc. | RNS |
| 11/12/23 | 07:00:15 | 11 Dec 2023 | | Broker Announcement | RNS |
| 11/12/23 | 07:00:11 | 11 Dec 2023 | | Parsortix unlocks opportunities for drug discovery | RNS |
| 05/12/23 | 07:00:14 | 5 Dec 2023 | | ANGLE launches Portrait+ CTC kit at SABCS | RNS |
| 09/11/23 | 07:00:19 | 9 Nov 2023 | | Launch of PD-L1 test to support cancer studies | RNS |
| 09/11/23 | 07:00:10 | 9 Nov 2023 | | Trading and business update | RNS |
| 25/10/23 | 07:00:14 | 25 Oct 2023 | | Supporting characterisation of CTCs in HNSCC | RNS |
| 03/10/23 | 07:00:09 | 3 Oct 2023 | | Parsortix outperforms standard for DTC harvest | RNS |
| 29/09/23 | 07:00:16 | 29 Sept 2023 | | Parsortix system showcased at ACTC conference | RNS |
| 07/09/23 | 07:00:04 | 7 Sept 2023 | | Interim Results for the period ended 30 June 2023 | RNS |
| 04/09/23 | 07:00:05 | 4 Sept 2023 | | ANGLE launch of Portrait Flex assay | RNS |
| 15/08/23 | 07:00:06 | 15 Aug 2023 | | ANGLE notice of interim results | RNS |
